CPMG Inc 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-28 4:30 pm Sale |
2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA |
CPMG Inc | 0 0.000% |
-5,020,431 (Position Closed) |
Filing |
| 2023-08-01 5:17 pm Sale |
2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA |
CPMG Inc | 5,020,431 14.300% |
-9,625 (-0.19%) |
Filing |
| 2020-12-29 5:31 pm Purchase |
2020-12-23 | 13D | Reata Pharmaceuticals, Inc. RETA |
CPMG Inc | 5,030,056 15.200% |
1,269 (+0.03%) |
Filing |